Literature DB >> 25170192

Non-pulmonary allergic diseases and inflammatory bowel disease: a qualitative review.

David S Kotlyar1, Mili Shum1, Jennifer Hsieh1, Wojciech Blonski1, David A Greenwald1.   

Abstract

While the etiological underpinnings of inflammatory bowel disease (IBD) are highly complex, it has been noted that both clinical and pathophysiological similarities exist between IBD and both asthma and non-pulmonary allergic phenomena. In this review, several key points on common biomarkers, pathophysiology, clinical manifestations and nutritional and probiotic interventions for both IBD and non-pulmonary allergic diseases are discussed. Histamine and mast cell activity show common behaviors in both IBD and in certain allergic disorders. IgE also represents a key immunoglobulin involved in both IBD and in certain allergic pathologies, though these links require further study. Probiotics remain a critically important intervention for both IBD subtypes as well as multiple allergic phenomena. Linked clinical phenomena, especially sinonasal disease and IBD, are discussed. In addition, nutritional interventions remain an underutilized and promising therapy for modification of both allergic disorders and IBD. Recommending new mothers breastfeed their infants, and increasing the duration of breastfeeding may also help prevent both IBD and allergic diseases, but requires more investigation. While much remains to be discovered, it is clear that non-pulmonary allergic phenomena are connected to IBD in a myriad number of ways and that the discovery of common immunological pathways may usher in an era of vastly improved treatments for patients.

Entities:  

Keywords:  Biomarkers; Crohn’s disease; Food allergies; Food intolerance; Inflammatory bowel disease; Nutrition; Pathophysiology; Probiotics; Ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 25170192      PMCID: PMC4145746          DOI: 10.3748/wjg.v20.i32.11023

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  84 in total

1.  Self-reported food intolerance in chronic inflammatory bowel disease.

Authors:  M Ballegaard; A Bjergstrøm; S Brøndum; E Hylander; L Jensen; K Ladefoged
Journal:  Scand J Gastroenterol       Date:  1997-06       Impact factor: 2.423

2.  Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.

Authors:  B I Korelitz; D H Present; P H Rubin; S E Fochios
Journal:  J Clin Gastroenterol       Date:  1984-02       Impact factor: 3.062

3.  Evening primrose oil and atopic eczema.

Authors:  D F Horrobin; P F Morse
Journal:  Lancet       Date:  1995-01-28       Impact factor: 79.321

4.  The immunoglobulin concentrations in serum and bowel secretion in patients with Crohn's disease.

Authors:  L Bergman; S G Johansson; U Krause
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

5.  Circulating and tissue eosinophils in ulcerative colitis.

Authors:  R Wright; S C Truelove
Journal:  Am J Dig Dis       Date:  1966-11

Review 6.  Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases.

Authors:  Warren Strober; Ivan J Fuss
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

Review 7.  Probiotics in clinical conditions.

Authors:  Philippe R Marteau
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

8.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

9.  Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea--a pilot study.

Authors:  K Plein; J Hotz
Journal:  Z Gastroenterol       Date:  1993-02       Impact factor: 2.000

Review 10.  Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders.

Authors:  Mitchell Kaplan; Ece A Mutlu; Mark Benson; Jeremy Z Fields; Ali Banan; Ali Keshavarzian
Journal:  Complement Ther Med       Date:  2006-08-21       Impact factor: 2.446

View more
  6 in total

Review 1.  The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces.

Authors:  Donjete Statovci; Mònica Aguilera; John MacSharry; Silvia Melgar
Journal:  Front Immunol       Date:  2017-07-28       Impact factor: 7.561

Review 2.  The Specific Roles of Vitamins in the Regulation of Immunosurveillance and Maintenance of Immunologic Homeostasis in the Gut.

Authors:  Koji Hosomi; Jun Kunisawa
Journal:  Immune Netw       Date:  2017-02-23       Impact factor: 6.303

3.  Histamine drives severity of innate inflammation via histamine 4 receptor in murine experimental colitis.

Authors:  J B Wechsler; A Szabo; C L Hsu; R A Krier-Burris; H A Schroeder; M Y Wang; R G Carter; T E Velez; L M Aguiniga; J B Brown; M L Miller; B K Wershil; T A Barrett; P J Bryce
Journal:  Mucosal Immunol       Date:  2018-01-24       Impact factor: 7.313

Review 4.  IL33: Roles in Allergic Inflammation and Therapeutic Perspectives.

Authors:  Ben C L Chan; Christopher W K Lam; Lai-Shan Tam; Chun K Wong
Journal:  Front Immunol       Date:  2019-03-04       Impact factor: 7.561

5.  Prevalence of allergic diseases in children with inflammatory bowel disease.

Authors:  Zuzanna Wasielewska; Aleksandra Dolińska; Dominika Wilczyńska; Anna Szaflarska-Popławska; Aneta Krogulska
Journal:  Postepy Dermatol Alergol       Date:  2019-06-18       Impact factor: 1.837

Review 6.  The Regulation of Intestinal Inflammation and Cancer Development by Type 2 Immune Responses.

Authors:  Reyes Gamez-Belmonte; Lena Erkert; Stefan Wirtz; Christoph Becker
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.